AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Gunasekera, RD Notghi, A Mostafa, AB Harding, LK
Citation: Rd. Gunasekera et al., Adsorption of radiopharmaceuticals to syringes leads to lower administeredactivity than intended, NUCL MED C, 22(5), 2001, pp. 493-497

Authors: Harding, LK Thomson, WH
Citation: Lk. Harding et Wh. Thomson, Radiation and pregnancy, Q J NUCL M, 44(4), 2000, pp. 317-324

Authors: Abram, WP Buxton-Thomas, M Carty, HML Clarke, SEM Coakley, AJ Cunningham, D Ell, P Elliott, AT Frier, M Gordon, I Gibson, CJ Gillen, GJ Harding, LK Henk, JM Hesslewood, SR Kendall, GM Lewington, V McCready, VR Mather, SJ McKillop, JH Millar, A Mountford, P Nunan, T Palmer, M Pippard, M Prescott, MC Shields, RA Stather, JW Stocks, MA Thomas, WH Tindale, W Waller, DG Watkinson, JC
Citation: Wp. Abram et al., Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources, NUCL MED C, 21, 2000, pp. III

Authors: Harding, LK
Citation: Lk. Harding, Justification and controllable dose - Reply, NUCL MED C, 21(9), 2000, pp. 871-871

Authors: Harding, LK Mills, AP Tulley, NJ
Citation: Lk. Harding et al., The BNMS Millennium Highlights Lecture, NUCL MED C, 21(8), 2000, pp. 705-706

Authors: Harding, LK
Citation: Lk. Harding, Justification and controllable dose, NUCL MED C, 21(4), 2000, pp. 309-310

Authors: Notghi, A Williams, NR Kehoe, S Smith, NB Harding, LK
Citation: A. Notghi et al., Estimation of ascitic fluid volume using Tc-99(m) labelled macroaggregatedalbumin, NUCL MED C, 21(12), 2000, pp. 1153-1156

Authors: Shields, RA Harding, LK
Citation: Ra. Shields et Lk. Harding, Comments on the British Institute of Radiology Working Party advice for patients after radionuclide therapy - Authors' reply, BR J RADIOL, 73(868), 2000, pp. 454-454

Authors: Barrington, SF O'Doherty, MJ Kettle, AG Thomson, WH Mountford, PJ Burrell, DN Farrell, RJ Batchelor, S Seed, P Harding, LK
Citation: Sf. Barrington et al., Radiation exposure of the families of outpatients treated with radioiodine(iodine-131) for hyperthyroidism, EUR J NUCL, 26(7), 1999, pp. 686-692

Authors: Barrington, SF O'Doherty, MJ Kettle, AG Thomson, WH Mountford, PJ Burrell, DN Farrell, RJ Batchelor, S Seed, P Harding, LK
Citation: Sf. Barrington et al., Contamination hazard due to iodine-131 therapy for thyrotoxicosis, EUR J NUCL, 26(12), 1999, pp. 1632-1632

Authors: Pauwels, EKJ Thomson, WH Blokland, JAK Schmidt, ME Bourguignon, M El-Maghraby, TAF Broerse, JJ Harding, LK
Citation: Ekj. Pauwels et al., Aspects of fetal thyroid dose following iodine-131 administration during early stages of pregnancy in patients suffering from benign thyroid disorders, EUR J NUCL, 26(11), 1999, pp. 1453-1457

Authors: Barrington, SF O'Doherty, MJ Kettle, AG Thomson, WH Mountford, PJ Burrell, DN Farrell, RJ Batchelor, S Seed, P Harding, LK
Citation: Sf. Barrington et al., Radiation exposure of the families of outpatients treated with radioiodine(iodine-131) for hyperthyroidism (vol 26, pg 686, 1999), EUR J NUCL, 26(10), 1999, pp. 1382-1382

Authors: Clarke, EA Notghi, A Harding, LK
Citation: Ea. Clarke et al., Can reduced imaging times be used for scintimammography?, NUCL MED C, 20(10), 1999, pp. 883-886

Authors: Ebdon-Jackson, S Gill, JR Harding, LK Murray, M Shields, RA Thomson, WH Wall, BF Williams, MK
Citation: S. Ebdon-jackson et al., Patients leaving hospital after administration of radioactive substances, BR J RADIOL, 72(854), 1999, pp. 121-125

Authors: Harding, LK Smith, NB
Citation: Lk. Harding et Nb. Smith, An interactive session: How do you do it?, NUCL MED C, 19(12), 1998, pp. 1115-1116
Risultati: 1-15 |